{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:34:53Z","timestamp":1791272093031,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ymgme.2012.01.016","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T11:31:57Z","timestamp":1327836717000},"page":"607-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation"],"prefix":"10.1016","volume":"105","author":[{"given":"Ayman W.","family":"El-Hattab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean W.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa T.","family":"Emrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Jun C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Craigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farook","family":"Jahoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.01.016_bb0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.1426","article-title":"Epidemiology and treatment of mitochondrial disorders","volume":"106","author":"Chinnery","year":"2011","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1146\/annurev.bi.61.070192.005523","article-title":"Diseases of the mitochondrial DNA","volume":"61","author":"Wallace","year":"1992","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00023210-200620060-00002","article-title":"The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) Syndrome. A review of treatment options","volume":"20","author":"Scaglia","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1142","author":"Sproule","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0170","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"l-Arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00688185","article-title":"Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy","volume":"74","author":"Ohama","year":"1987","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.42.3.545","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation","volume":"42","author":"Goto","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0045","first-page":"87","article-title":"Hypocitrullinemia in patients with MELAS: an insight into the \u201cMELAS paradox\u201d","volume":"229","author":"Naini","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2004.068197","article-title":"Effect of exercise training on endothelium-derived nitric oxide function in humans","volume":"561","author":"Green","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/pr.55.2.3","article-title":"The pharmacology of nitric oxide in the peripheral nervous system of blood vessels","volume":"55","author":"Toda","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0175","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0006-291X(88)81362-7","article-title":"l-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation","volume":"153","author":"Palmer","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0065","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The l-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochemical"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1152\/ajpregu.90506.2008","article-title":"Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension","volume":"296","author":"Wang","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0095","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/meta.2002.33349","article-title":"Metformin treatment lowers asymmeteric dimethylarginine concentrations in patients with type 2 diabetes","volume":"51","author":"Asagami","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.27.3.765","article-title":"Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes","volume":"27","author":"Tarnow","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mito.2006.11.006","article-title":"MELAS and l-arginine therapy","volume":"7","author":"Koga","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.2000.3169","article-title":"Regulation of nitric oxide production by arginine metabolic enzymes","volume":"3","author":"Mori","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/CS20080444","article-title":"Arginine, citrulline and nitric oxide metabolism in sepsis","volume":"117","author":"Kao","year":"2009","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0378-4347(94)00374-2","article-title":"Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography\u2013mass spectrometry using their 15N-labelled analogs","volume":"661","author":"Tsikas","year":"1994","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ajcn\/86.4.1024","article-title":"Arginine flux and intravascular nitric oxide synthesis in severe childhood undernutrition","volume":"86","author":"Jahoor","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0130","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1073\/pnas.90.16.7749","article-title":"Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets","volume":"90","author":"Castillo","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ajcn\/84.1.197","article-title":"In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis","volume":"84","author":"Villalpando","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0185","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002964","article-title":"Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement","volume":"10","author":"Vattemi","year":"2011","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.ymgme.2012.01.016_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s004310051009","article-title":"The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia","volume":"55","author":"Parfait","year":"1999","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0150","doi-asserted-by":"crossref","first-page":"1621S","DOI":"10.1093\/jn\/137.6.1621S","article-title":"Citrulline: a new player in the control of nitrogen homeostasis","volume":"137","author":"Moinard","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0155","doi-asserted-by":"crossref","first-page":"1527S","DOI":"10.1093\/jn\/135.6.1527S","article-title":"Overview of the molecular and biochemical basis of branched-chain amino acid catabolism","volume":"135","author":"Harris","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2012.01.016_bb0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.clnu.2008.05.007","article-title":"New indications and controversies in arginine therapy","volume":"27","author":"Coman","year":"2008","journal-title":"Clin. Nutr."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:20:53Z","timestamp":1761088853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1096719212000200"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.01.016","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}